Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

There wasn't much sales growth this quarter, but the company did improve its bottom line.

4 Reasons to Sell Canopy Growth Stock After Its Q1 Earnings (and 2 Reasons to Buy)

CGC stock has taken its investors on a wild ride on their way to success. They are doing this while plowing new trails for a new industry.

Canopy Growth Stock Has a Bright Light at the End of the Tunnel

This successful cannabis company is not only increasing its revenue splendidly, but it also has billions of dollars in cash and investments.

Got $1,000 in Cash? Here's the Top Pot Stock to Buy Now

Aurora Cannabis

HEXO Corp

Is there hope for these three companies that once rocked the Canadian marijuana industry?

Can These Once-Hot Pot Stocks Recover?

The largest pot stock in the world's first-quarter operating results aren't that impressive if you do a little digging.

5 Reasons Canopy Growth's Q1 Report Was Actually a Dud

Aphria

Cronos Group

OrganiGram Holdings Inc.

Marijuana stocks could rally in a big way if Democrats seize control of the House, Senate and White House in November.
The post 5 Marijuana Stocks to Buy For A “Blue Wave” Election appeared first on InvestorPlace.

5 Marijuana Stocks to Buy For A “Blue Wave” Election

Canopy Growth beat on earnings and revenue expectations, but CGC stock is having trouble rallying. Here's how to look at the stock now.

Must-Watch Support for Canopy Growth Stock

Altria

New Age Beverages

Constellation Brands

Many aspects of the marijuana industry are now encountering growing pains.

3 Red-Hot Cannabis Trends That Have Fizzled Out

Canopy Growth Corporation.'s (CGC) CEO Mike Lee on Q1 2021 - Earnings Call Transcript

Cannabis-infused drinks helped produce a fizzier-than-expected quarter for the company.

Canopy Growth Closes Nearly 8% Higher on Q1 Bottom-Line Beat

Canopy Growth Corp’s (NYSE: CGC) first-quarter results reflected the company’s transition phase, with a new organization structure, trimmed strategy and supply chain review.

Cantor Raises Canopy Growth Target After Q1 Earnings Call

Canopy Growth's strong earnings report confirmed that all the pieces are in place for CGC stock to rip higher over the next few quarters. 
The post Strong Canopy Growth Earnings Make CGC Stock a Buy appeared first on InvestorPlace.

Strong Canopy Growth Earnings Make CGC Stock a Buy

Canopy Growth earnings on Monday have CGC stock higher after the company reported improved figures for the first quarter of fiscal year 2021.
The post Canopy Growth Earnings: CGC Stock Rises 10% on Improved Q1 Numbers appeared first on InvestorPlace.

Canopy Growth Earnings: CGC Stock Rises 10% on Improved Q1 Numbers

Canopy Growth Corp. (NYSE: CGC) reported first-quarter fiscal 2021 results before markets opened Monday.

Is That a Light at the End of the Tunnel for Canopy Growth?

Canopy Growth Corp. (TSE: WEED) said on Monday that its net loss in the fiscal first quarter contracted on an annualised basis.

Canopy Growth’s revenue comes in 22% higher in the fiscal Q1

The U.S.-listed shares of Canopy Growth Corp. CGC, -5.08% WEED, -4.41% charged up 6.8% in premarket trading Monday, after the Canada-based cannabis company reported a narrower-than-expected fiscal first-quarter loss, although revenue rose less than forecast.

Canopy Growth's stock surges after narrower-than-expected loss, while revenue comes up short

Transformation strategy gains traction Net Revenue of $110 million increases 22% over Q1 FY20 Net Loss of $128 million; Adjusted EBITDA loss of $92 million narrows versus Q1 FY20 Established leadership position in growing cannabis-infused beverage segment; shipping +1.2mm cans to Canadian.

Canopy Growth Reports First Quarter Fiscal 2021 Financial Results

Not all is rosy for this cannabis giant. Here are a few things you should keep in mind about Canopy.

3 Reasons I'm Cautious About Canopy Growth Stock

Despite the impact of the pandemic on the second quarter, Medical Product companies have shown strength on the back of huge adoption of COVID-19 related healthcare-support products and services.

Medical Products Stock Earnings on Aug 10: CGC, SDGR & More

These companies are still very bullish on marijuana.

2 Non-Pot Stocks That Invested More in the Cannabis Industry This Year

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Marijuana legalization initiatives will be on the ballot in a number of states in November.

4 Cannabis Stocks Poised to Profit From Legalization Votes

The move is part of an aggressive push into the U.S. CBD market segment.

Canopy Growth Supplement Brand Signs Endorsement Deal With Super Bowl MVP Mahomes

Canopy Growth (CGC) reports Q1 FY 2021 earnings after market close on August 10. Can the company reverse huge losses and improve its negative free cash flow?

Canopy Growth Earnings: What to Look For From CGC

Canopy Growth Corporation (CGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Canopy Growth Corporation (CGC) to Report a Decline in Earnings: What to Look Out for

Continued momentum from robust product demand is expected to have significantly contributed to Canopy Growth's (CGC) top line in the fiscal first quarter.

News for Canopy Growth Stock (CGC)